Navigation Links
Paragon Bioservices Appoints Dr. Vadim Klyushnichenko as Vice President of Preclinical Services and Process Development
Date:7/20/2011

BALTIMORE, July 20, 2011 /PRNewswire/ -- Paragon Bioservices, Inc., a Baltimore-based contract research and GMP manufacturing organization, announced today the appointment of Vadim Klyushnichenko, Ph.D. as Vice President, Preclinical Services and Process Development.  He will report to Paragon's President and CEO Marco Chacon, Ph.D.

Dr. Klyushnichenko has more than 15 years experience in biopharmaceutical project management, analytical development and formulation, process development, engineering and scale-up from pilot to GMP manufacturing, technology transfer and regulatory filing.

He developed his managerial and scientific background working as Vice President of Drug Development at both Terapio (Austin, TX) and Coldstream Laboratories, Lab Head at Wyeth BioPharma, and Senior Scientist positions at Epic Therapeutics (Baxter), Altus Biologics in Boston and Aventis/Sanofi Pasteur.

Dr. Klyushnichenko received his M.S., Engineering from Moscow Institute of Physics and Technology, and a  Ph.D. in Chemistry from the Shemyakin Institute of Bioorganic Chemistry in Moscow. His additional research in Analytical Biochemistry and Process Development includes the Humboldt University in Berlin, Dusseldorf University, and the Biotechnology Research Institute in Montreal.  He is also a Certified Professional Project Manager (PMP/PMI) and holds a Certificate of Special Studies (CSS) in Administration and Management from Harvard University.

Dr. Chacon stated, "We feel that Vadim will be a great addition to Paragon's team as we continue to add personnel, double our process development and GMP manufacturing and add fill-and-finish capabilities to our facility."

About Paragon Bioservices

Paragon Bioservices is a contract research and manufacturing organization (CMO) that provides a comprehensive portfolio of services—from research services and process development to cGMP manufacturing of monoclonal antibodies, therapeutic proteins, vaccines and VLPs, and stem cells.  The corporate focus is to bridge the translational divide and enable protein and cell-based therapeutics to move into clinical trials.

Media contacts:
Tiberend Strategic Advisors, Inc.
212-827-0020
Tamara Bright: tbright@tiberend.com
or
Claire Sojda: csojda@tiberend.com


'/>"/>
SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paragon Bioservices to Partner and Exhibit at the 2011 BIO International Convention
2. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
3. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
4. HYCOR Appoints Sean-Xavier Neath as Chief Medical Officer to Support Expansion of Product Lines and Enhance Customer Support Offerings
5. CoLucid Appoints Thomas P. Mathers as Chief Executive Officer
6. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
7. GenturaDx Appoints Senior Vice President of Research & Development
8. H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care
9. OncoSec Medical Appoints Engineering Leader
10. Tris Pharma Appoints Vice President of Human Resources
11. Cepheid Appoints Vice President of Infectious Disease Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Calif. and KANSAS CITY, ... Children,s Hospitals Neonatal Consortium (CHNC) has selected Velos ... their visionary data management and multicenter initiatives. ... organization comprised of 32 Neonatal Intensive Care Units ... America . The consortium provides a benchmark ...
(Date:1/17/2017)... , Jan. 17, 2016  Attorney Advertising -- Bronstein, Gewirtz ... purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ... additional information and assist the investigation by visiting the firm,s ... Anthera and certain of its officers and/or directors have violated ... 1934. ...
(Date:1/17/2017)...   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, ... research and pharmaceutical development at Tocagen, will present at Phacilitate ... 17-20 in Miami . Details ... ... replicating viruses - what to do when and why Date and ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... ... companies and ranked among the top US security companies for consecutive years, today ... This announcement brings a year-long independent board nomination process to a close and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... Center and the Montclair State University’s Athletic Training Education program forged a relationship ... Athletic Training Education Program, which is consists of both student members and ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening Event planned for ... use by sports teams and the general public. Built in five months by Centerpoint, ... be converted into basketball or pickleball courts. The space is also suitable for indoor ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s ... Victor Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, ... Eye Care, a division of SightMD. Dr. Giamos will practice primarily out of ...
Breaking Medicine News(10 mins):